Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/37417
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_AdvancesNanocarriersDrug.pdf1,46 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorQuijia Quezada, Christian-
dc.contributor.authorAzevedo, Clênia dos Santos-
dc.contributor.authorCharneau, Sébastien-
dc.contributor.authorSantana, Jaime Martins-
dc.contributor.authorChorilli, Marlus-
dc.contributor.authorCarneiro, Marcella Bretas-
dc.contributor.authorBastos, Izabela Marques Dourado-
dc.date.accessioned2020-04-09T13:09:01Z-
dc.date.available2020-04-09T13:09:01Z-
dc.date.issued2019-08-09-
dc.identifier.citationQUIJIA QUEZADA, Christian et al. Advances in nanocarriers as drug delivery systems in Chagas disease. International Journal of Nanomedicine, v. 14, p. 6407–6424, 2019. DOI: https://doi.org/10.2147/IJN.S206109. Disponível em: https://www.dovepress.com/advances-in-nanocarriers-as-drug-delivery-systems-in-chagas-disease-peer-reviewed-article-IJN. Acesso em: 09 abr. 2020.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/37417-
dc.language.isoInglêspt_BR
dc.publisherDove Presspt_BR
dc.rightsAcesso Abertopt_BR
dc.titleAdvances in nanocarriers as drug delivery systems in Chagas diseasept_BR
dc.typeArtigopt_BR
dc.subject.keywordNanopartículaspt_BR
dc.subject.keywordNanobiossensorespt_BR
dc.subject.keywordDiagósticopt_BR
dc.subject.keywordChagas, Doença de - tratamentopt_BR
dc.subject.keywordVacinaspt_BR
dc.rights.license© 2019 Quijia Quezada et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)pt_BR
dc.description.abstract1Chagas disease is one of the most important public health problems in Latin America due to its high mortality and morbidity levels. There is no effective treatment for this disease since drugs are usually toxic with low bioavailability. Serious efforts to achieve disease control and eventual eradication have been unsuccessful to date, emphasizing the need for rapid diagnosis, drug development, and a reliable vaccine. Novel systems for drug and vaccine administration based on nanocarriers represent a promising avenue for Chagas disease treatment. Nanoparticulate systems can reduce toxicity, and increase the efficacy and bioavailability of active compounds by prolonging release, and therefore improve the therapeutic index. Moreover, nanoparticles are able to interact with the host’s immune system, modulating the immune response to favour the elimination of pathogenic microorganisms. In addition, new advances in diagnostic assays, such as nanobiosensors, are beneficial in that they enable precise identification of the pathogen. In this review, we provide an overview of the strategies and nanocarrier-based delivery systems for antichagasic agents, such as liposomes, micelles, nanoemulsions, polymeric and non-polymeric nanoparticles. We address recent progress, with a particular focus on the advances of nanovaccines and nanodiagnostics, exploring new perspectives on Chagas disease treatment.pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.